Randomized Trial of Adjuvant Tamoxifen and/or Goserelin in Premenopausal Breast Cancer-Self-rated Physiological Effects and Symptoms

By Nystedt Marianne   Berglund Gunilla   Bolund Christina   Brandberg Yvonne   Fornander Tommy   Rutqvist Lars Erik  

Acta Oncologica, Vol. 39, Iss. 8, 2000-11 ,pp. : 959-968

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant endocrine therapy in premenopausal women with breast cancer

By González Martín Antonio   Cruz Susana   Márquez Raúl  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-09 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite

Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study

By Hadji Peyman   Kauka Annette   Ziller May   Birkholz Katrin   Baier Monika   Muth Mathias   Kann Peter  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 343-351

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial

By                      

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1707-1713

Spandidos Publications

Access to resources Recommend Favorite

Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials

By Zhou Wen-Bin  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 625-631

Springer Publishing Company

Access to resources Recommend Favorite